Fluidigm Corporation (FLDM:NASDAQ) Investor Relations Material

Overview

Fluidigm Corporation is a technology company that specializes in developing and producing tools for the exploration and analysis of single cells, as well as the industrial application of genomics. The company offers various instruments, including the C1 single-cell auto prep system, which isolates, processes, and profiles individual cells for genomic analysis, and access array systems that enable automated polymerase chain reaction (PCR)-based target enrichment, barcoding, and tagging of resequencing libraries. The company's tools provide a wide range of applications, from basic research in molecular biology to industrial-scale genomics analysis, and are widely used by researchers, universities, and biotech companies around the world.

Frequently Asked Questions

What is Fluidigm Corporation's ticker?

Fluidigm Corporation's ticker is FLDM

What exchange is Fluidigm Corporation traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Fluidigm Corporation's headquarters?

They are based in South San Francisco, California

How many employees does Fluidigm Corporation have?

There are 501-1000 employees working at Fluidigm Corporation

What is Fluidigm Corporation's website?

It is https://www.fluidigm.com/

What type of sector is Fluidigm Corporation?

Fluidigm Corporation is in the Healthcare sector

What type of industry is Fluidigm Corporation?

Fluidigm Corporation is in the Medical Laboratories & Research industry

Who are Fluidigm Corporation's peers and competitors?

The following five companies are Fluidigm Corporation's industry peers:

- Laboratory Corporation of America

- Neo Performance Materials

- Organovo Holdings Inc

- Invitae

- Psychemedics Corp.